CENTRAL VENOUS CATHETER REMOVAL

This adverse event was reported 469 times

These drugs are most commonly taken by patients reporting CENTRAL VENOUS CATHETER REMOVAL:

# Drug Count
0 AMBRISENTAN 36
1 ERGOCALCIFEROL 30
2 SILDENAFIL CITRATE 30
3 NIRAPARIB 25
4 TADALAFIL 25
5 EPINEPHRINE 23
6 IBRUTINIB 23
7 ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC FUSION PROTEIN 22
8 EPOPROSTENOL 22
9 TREPROSTINIL 22
See all common drugs associated with CENTRAL VENOUS CATHETER REMOVAL

CENTRAL VENOUS CATHETER REMOVAL is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC FUSION PROTEIN 22 0.0058
1 C1 ESTERASE INHIBITOR RECOMBINANT 16 0.0025
2 ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC-VWF-XTEN FUSION PROTEIN-EHTL 4 0.0024
3 LANADELUMAB-FLYO 6 0.0019
4 EPOPROSTENOL 22 0.0017
5 STERILE WATER FOR INJECTION 8 0.0015
6 IDURSULFASE 5 0.0013
7 HUMAN C1-ESTERASE INHIBITOR 18 0.0012
8 LARONIDASE 5 0.0012
9 NIRAPARIB 25 0.0011
See all drugs enriched for association with CENTRAL VENOUS CATHETER REMOVAL